Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Nonpeptide caspase inhibitor holds promise for patients with fulminant hepatic failure

Jan. 15, 2001

Phase III compound for liver diseases licensed by Interneuron

Jan. 12, 2001

FDA clearance sought to begin clinical trials of levovirin

Jan. 11, 2001

IMP dehydrogenase inhibitors potentiate anti-HBV activity of nucleoside analogues

Jan. 11, 2001

Prospective trial compares efficacy of teprenone and rabeprazole against NSAID-induced GI lesions

Jan. 10, 2001

New series of sphingomyelinase inhibitors described by Ono researchers

Jan. 8, 2001

Pregabalin may have beneficial effects in the treatment of abdominal pain

Jan. 3, 2001

Global rights for novel Japanese antiviral agent granted to Lilly

Jan. 2, 2001

Elan/Incara partnership plans immediate entry into pivotal IBD trials for OP-2000

Jan. 2, 2001

Viragen staged to begin U.S. clinical trials with Omniferon

Jan. 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...